- Secondary MDS/AML after autologous SCT for lymphoma with BEAM regime +1Publication without faculty affiliation
- Therapy-related MDS/AML after autologous stem cell transplantation for lymphoma with BEAM as conditioning: our experience +12008 | Faculty of Medicine in Hradec Králové
- Therapy-related MDS/AML after autologous stem cell transplantation for lymphoma with BEAM as conditioning: our experience2008 | First Faculty of Medicine
- Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies2012 | First Faculty of Medicine
- Retrospective study of deletions of 5q in patients with myelodysplastic syndrome (MDS) or acute maeloid leukemia (AML)Publication without faculty affiliation
- Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients2021 | First Faculty of Medicine
- Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Combination of molecular cytogenetic techniques in mapping of the atypical 5q deletion in myeloid malignanciesPublication without faculty affiliation
- Deficit of GATA-2 transcription factor: new immunodeficiency syndrome with broad phenotype. First patients diagnosed in the Czech Republic and review of the literature2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Czech MDS Group experience with azacitidine in treatment of high risk MDS and AML patientsPublication without faculty affiliation
- Genomic imbalances in 73 patients with MDS and complex karyotypesPublication without faculty affiliation
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- Heterogenity of telomere lenght and telomerase activity in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and their prognostic value for leukemic transformationPublication without faculty affiliation
- Deletion of 5q in hematological malignanciesPublication without faculty affiliation
- Dynamics of telomerw erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemi arising from MDS: a marker of disease prognosis?2004 | First Faculty of Medicine
- Dynamics of telomerw erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemi arising from MDS: a marker of disease prognosis?2004 | Faculty of Physical Education and Sport
- Immunosuppressive therapy combining anti-thymocyte globulin and cyclosporine A in childhood acquired aplastic anaemia - long term-outcomes and risks2012 | Second Faculty of Medicine
- Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways2022 | First Faculty of Medicine
- Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 71999 | Second Faculty of Medicine